$ Value
$0
Shares
132,693
Price
$0
Filed
Apr 20
Insider
Name
KAKKIS EMIL D
Title
President & CEO
CIK
0001248093
Roles
Transaction Details
Transaction Date
2026-04-16
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
132,693
Footnotes
Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date | Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. | Amount of securities beneficially owned following reported transaction reflects the contribution of an aggregate of 400,000 shares previously owned indirectly by the reporting person to two grantor retained annuity trusts (each, a "GRAT"). | On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Filing Info
Other Insiders at RARE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
KAKKIS EMIL D
President & CEO
|
— | — | 2026-04-16 |
|
Huang Dennis Karl
See Remarks
|
— | — | 2026-04-16 |
|
Pinion John Richard
See Remarks
|
— | — | 2026-04-16 |
|
Crombez Eric
EVP and Chief Medical Officer
|
— | — | 2026-04-16 |
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
|
— | — | 2026-04-16 |
|
Harris Erik
EVP & Chief Commercial Officer
|
— | — | 2026-04-16 |
|
Horn Howard
Chief Financial Officer
|
— | $98K | 2026-04-16 |